In this Issue
Insights and Perspectives
Chief Medical Editors’ Page
By Ted E. Feldman, MD, MSCAI, FACC, FESC; and Bernard Prendergast, BMedSci, BM BS, MRCP, DM, FRCP, FESC
What these ongoing data tell us about TAVR and future areas of interest.
By Frederick L. Grover, MD; and David R. Holmes Jr, MD
From clinical research to standard-of-care procedural planning.
By Hasan Jilaihawi, MD
Can it be done, and is this approach reliable and accurate?
By Nishath Quader, MD
Technical characteristics and evidence to date for FDA- and CE Mark-approved valves.
By Denise Todaro, MD; Andrea Picci, MD; and Marco Barbanti, MD
Devices in early clinical development, including devices with early human experience and those originating from China.
By Thomas Modine, MD, PhD, MBA; Darren Mylotte, MD; and Nicolo Piazza, MD, PhD
Potential pitfalls as the use of TAVR is extended to low- and intermediate-risk patients.
By Andrew Roy, MD, FESC; Dinesh Natarajan, MBBS, BMedSci; and Bernard Prendergast, BMedSci, BM BS, MRCP, DM, FRCP, FESC
Several institutions share their methods for treating patients with coronary artery disease who undergo transcatheter aortic valve replacement.
With Lowell Satler, MD; Toby Rogers, MD, PhD; Jubin Joseph, MA, BMBCh; Simon R. Redwood, MD; Giuliana Capretti, MD; Alaide Chieffo, MD; and Antonio Colombo, MD
The hemodynamics and utility of IABP counterpulsation in current practice.
By Lokien X. van Nunen, MD, PhD
Dr. von Bardeleben provides insight into ongoing mitral valve trials and discusses use of mitral devices for tricuspid disease, as well as imaging protocols for transcatheter mitral valve interventions.